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Abstract 
 
Brain abnormalities persist in individuals with human immunodeficiency virus (HIV) 
despite the use of highly active antiretroviral therapy (HAART). To date, limited work 
has focused on the association between early life stress (ELS) and brain integrity in 
individuals with HIV, although ELS is highly prevalent in this population. The present 
study was conducted to determine whether ELS corresponds to the expression of 
persistent HIV–related neuroimaging abnormalities and cognitive dysfunction. A total of 
130 HIV+ individuals on HAART and 76 HIV– individuals underwent 3T structural 
magnetic resonance imaging, diffusion tensor imaging, and neuropsychological 
assessment. Individuals were free of major psychiatric illness and neurological 
confounds. Participants were stratified into high or low ELS groups based on self-
reported exposure to early life adversity using the Early Life Stress Questionnaire 
(ELSQ). No significant interactions were observed between HIV serostatus and ELS on 
white matter microstructural integrity, brain volumes, or cognition. However, HIV+ 
individuals exhibited significantly greater whole-brain white matter microstructural 
abnormalities, smaller brain volumes, and worse cognition compared to the HIV– group. 
Collapsed across HIV serostatus, individuals with high ELS demonstrated more severe 
whole-brain white matter microstructural abnormalities compared to individuals with low 
ELS. Results of present study suggest that high ELS is not a primary contributor to the 
neuropathogenic model of HIV in HAART-treated individuals. Evidence of persistent 
brain abnormalities among treated HIV+ individuals is consistent with results from other 
studies, further emphasizing the need to monitor cognitive health in patients after 
sustained HIV treatment.  
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Neuroimaging and cognitive outcomes in adults with human immunodeficiency virus and 
early life stress 
Human Immunodeficiency Virus (HIV) is a significant public health concern. The 
World Health Organization (WHO) estimates that over 35 million HIV+ individuals are 
currently living with the disease, with thousands of new cases diagnosed each year 
(WHO, 2017). Survival rates have improved dramatically since the introduction of highly 
active antiretroviral therapy (HAART) (Egger et al., 1997; Palella et al., 1998, 2006; 
Powderly, 2002). However, HIV penetrates the blood brain barrier within days of 
infection and is highly neurovirulent (Valcour et al., 2012), leading to inflammation and 
neuronal dysfunction. Despite the effectiveness of HAART in reducing viral load, 
increasing CD4 T-cell counts, and reducing opportunistic infections, current treatments 
do not prevent or reverse HIV–related brain damage (Ances, Ortega, Vaida, Heaps, & 
Paul, 2012; Harezlak et al., 2011; Heaton et al., 2011).  
Nearly half of all HIV+ patients exhibit some degree of neurocognitive 
impairment (Heaton et al., 2010; Heaton et al., 2011). There is a broad spectrum of 
cognitive variability in this population, with some individuals experiencing minimal or no 
cognitive dysfunction and others demonstrating dementia, the latter considered rare 
among individuals on suppressive antiretroviral treatment (Heaton et al., 2011; Robertson 
et al., 2007; Simioni et al., 2010). Consequently, understanding the role that co-morbid 
conditions play in the etiology of HIV–related neuroimaging abnormalities and cognitive 
dysfunction has become increasingly important. Nadir CD4 T-cell count, older age, and 
hepatitis C (HCV) co-infection contribute to cognitive variability in HIV (Becker, Lopez, 
Dew, & Aizenstein, 2004; Cherner et al., 2005; Devlin et al., 2012; Ellis et al., 2011; 
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Gongvatana et al., 2011; Hinkin, Castellon, Levine, Barclay, & Singer, 2008; Valcour et 
al., 2004, 2006).  
 Emerging evidence indicates that early life stress (ELS) may increase the risk of 
brain dysfunction in individuals with HIV (Clark et al., 2012; Clark, Sweet, Morgello, 
Philip, & Cohen, 2016; Spies et al., 2016). ELS is defined as one or more events during 
childhood that exceed a child’s coping resources (Pechtel & Pizzagalli, 2011). Early life 
stressors include, but are not limited to, physical abuse, sexual abuse, emotional abuse, 
neglect, bullying, parental divorce, death of a family member, and sustained family 
conflict (De Bellis & Keshavan, 2003; Harrison, Fulkerson, & Beebem, 1997; McGee, 
Wolfe, Yuen, Wilson, & Carnochan, 1995; Sanders & Becker-Lausen, 1995). Notably, 
ELS is associated with an increased risk for depression and PTSD, as well as numerous 
medical conditions (e.g., cardiovascular disease, diabetes) in adulthood (Anda et al., 
2002; Cicchetti, 2004; Dong et al., 2004; Edwards, Holden, Felitti, & Anda, 2003; Enoch, 
2011; Nemeroff, 2016). Furthermore, a growing body of evidence indicates that ELS 
exerts pathological effects on the brain in otherwise healthy individuals (Andersen et al., 
2008; Baker et al., 2013; Choi, Jeong, Rohan, Polcari, & Teicher, 2009; Cohen et al., 
2006a; Gatt et al., 2009; Paul et al., 2008; Seckfort et al., 2008). Given that ELS is highly 
prevalent in HIV+ individuals (up to 76%; Simoni & Ng, 2000; Spies et al., 2012; Villar-
Loubet et al., 2014; Walton et al., 2011) and detrimental to health, it is important to 
examine the relevance of ELS on brain integrity in HIV+ individuals. 
ELS on Gray Matter and Cognitive Outcomes in HIV 
 Clark and colleagues (2012) conducted the first study to examine ELS on brain 
volumes and cognition in HIV+ individuals in comparison to HIV– controls. The Early 
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Life Stress Questionnaire (ELSQ; Sanders & Becker-Lausen, 1995) was administered to 
capture a range of ELS subtypes including interpersonal conflict, divorce, health, 
bullying, war, and natural disasters. HIV+ and HIV– individuals were classified as high 
ELS if they endorsed ≥ 3 events and low ELS if they reported < 3 events on the ELSQ. 
Results revealed significantly reduced psychomotor/processing and amygdala 
hypertrophy in HIV+ individuals with high ELS compared to HIV+ individuals with low 
ELS and HIV– controls. The finding of larger amygdala volume is unexpected as HIV+ 
adults typically exhibit lower brain volumes compared to HIV– controls (Ances et al., 
2006, 2012; Behrman-Lay et al., 2016; Baker et al., 2015; Becker et al., 2012; Paul et al., 
2016; Sanford et al., 2017).  
More recently, Spies and colleagues (2016) examined the association between 
ELS and structural neuroimaging outcomes and cognitive performance in a sample of 
HIV+ females in South Africa. In this study, ELS was defined as a score of ≥ 41 on the 
Childhood Trauma Questionnaire- Short Form (CTQ-SF; Bernstein et al., 2003). Unlike 
the ELSQ, the CTQ-SF only examines childhood abuse and neglect. In this study, HIV+ 
females with ELS demonstrated smaller volumes of the anterior cingulate cortex, 
hippocampus, corpus callosum, caudate, and putamen compared with HIV+ females with 
no ELS and HIV– controls. Smaller brain volumes significantly correlated with worse 
performance on tests of motor skills, processing speed, learning, verbal fluency, 
attention/working memory, and abstraction/executive function (Supplemental Table 1). 
These results are consistent with the phenotype of HIV-related brain dysfunction (Ances 
et al., 2006, 2012; Behrman-Lay et al., 2016; Baker et al., 2014, 2015; Becker et al., 
2012; Paul et al., 2014, 2016; Sanford et al., 2017; Spudich, 2013).  
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 The two studies conducted to date suggest a deleterious correspondence between 
ELS and cognition, but inconsistent neuroimaging outcomes. Clark and colleagues (2012) 
revealed an isolated effect of ELS on amygdala hypertrophy in HIV+ individuals with 
high ELS, whereas Spies et al. (2016) demonstrated smaller volumes in numerous brain 
regions in HIV+ individuals with abuse and neglect compared with controls, in the 
absence of differences in amygdala volume. The conflicting results may reflect a number 
of cohort and methodological discrepancies between the studies, including depression 
status, self-report scales, select focus on abuse and neglect in the studies conducted by 
Spies et al. (2016), HIV treatment status, and viral load. The majority of participants 
enrolled by Clark et al. (2012) were on HAART (84%) and evidenced an undetectable 
viral load (74%). By contrast, less than 50% of the participants enrolled by Spies et al. 
(2016) were on HAART and, on average, exhibited a high viral load (M = 116,172 
copies/ml). While it is possible that these differences may have contributed to the more 
robust neuroimaging outcomes observed in Spies et al. (2016), the specific explanation 
for the discrepancies between studies remains unknown. 
ELS and White Matter in HIV 
 To date, studies have not examined the relationship between ELS and brain white 
matter. Specifically, white matter disruption (e.g., myelin pallor) is recognized as a 
neuroimaging abnormality related to HIV (Baker et al., 2017; Chen et al., 2009; Pomara, 
Crandall, Choi, Johnson, & Lim, 2001; Paul et al., 2016). ELS also related to pronounced 
neuroimaging abnormalities in brain white matter among HIV– individuals with and 
without psychopathology (e.g., Posttraumatic Stress Disorder [PTSD]; Anderson, 2008; 
Choi et al., 2009; Choi, Jeong, Polcari, Rohan, & Teicher, 2012; Paul et al., 2008; 
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Seckfort et al., 2008; Wang et al., 2010). Therefore, it is possible that ELS contributes to 
the etiology of white matter abnormalities that underlie some of the cognitive dysfunction 
in HIV. Investigating the association between ELS and white matter integrity in HIV+ 
individuals may help determine whether ELS-related mechanisms (e.g., HPA-axis 
dysfunction) represent new potential therapeutic targets for HIV-associated 
neurocognitive disorders. 
Diffusion Tensor Imaging 
Diffusion tensor imaging (DTI) measures the movement (diffusion) of water 
molecules in brain tissue. The imaging modality is particularly sensitive to alterations in 
white matter microstructure (Le Bihan et al., 2001). Damage to white matter pathways 
alters the speed and direction of diffusion along white matter fiber lengths and these 
changes can be quantified using DTI (Alexander, Lee, Lazar, & Field, 2007; Charlton et 
al., 2006; Song et al., 2002; Madden et al., 2012; Whitford, Kubicki, & Shenton, 2011). 
Common DTI indices include fractional anisotropy (FA), representing the ratio of 
directional to nondirectional diffusion, and mean diffusion (MD), representing 
unrestricted (isotropic) diffusion. Intact white matter is defined by highly anisotropic 
(directionally constrained) water diffusion (high FA, low MD), due to the underlying 
anatomy of the axon and the myelin sheath (Basser & Pierpaoli, 1996). Axial diffusivity 
(AD) and radial diffusivity (RD) characterize diffusion that occurs parallel (AD) and 
perpendicular (RD) to axons, likely representing axonal and myelin integrity, respectively 
(Alexander et al., 2007; Song et al., 2002).  
Diffusion Tensor Imaging and Cognitive Studies of HIV 
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HIV is frequently associated with reduced FA, suggestive of reduced white matter 
integrity (Chen et al., 2009; Filippi, Ulu, Ryan, Ferrando, & van Gorp. 2001; Gongvatana 
et al., 2009; Hoare et al., 2012a; Leite et al., 2013; Pomara et al., 2001; Wang et al., 
2015). Some studies also report increased MD, RD, and AD in chronically infected 
individuals, yet this pattern is not consistently observed. When present, DTI 
abnormalities associated with HIV are commonly observed in the frontal white matter 
and the corpus callosum (Cloak, Chang, & Ernst, 2004; Filippi et al., 2001; Heaps-
Woodruff, Wright, Ances, Clifford, & Paul, 2016; Paul et al., 2016; Pomara et al., 2001; 
Thurnher et al., 2005; Wu et al., 2006). Research also indicates reduced white matter 
microstructural integrity in tracts that project to the frontal lobe, including the anterior 
thalamic radiation, inferior fronto-occipital fasciculus, superior longitudinal fasciculus, 
cingulum bundle (cingulate gyrus and hippocampal segments of cingulum), and uncinate 
fasciculus (Gongvatana et al., 2009; Hoare et al., 2012b; Li et al., 2015; Paul et al., 2016; 
Pfefferbaum et al., 2009; Stubbe-Dräger et al., 2012; Tate et al., 2010; Wang et al., 2015; 
Wu et al., 2006; Zhu et al., 2013). DTI abnormalities in these tracts are associated with 
worse performance on tests of learning, memory, psychomotor/processing speed, gross 
motor, and executive function (Gongvatana et al., 2009; Hoare et al., 2012a&b; Stubbe -
Dräger et al., 2012; Wu et al., 2006), emphasizing the functional significance of white 
matter disruption in the context of HIV. 
Diffusion Tensor Imaging and Cognitive Studies of ELS 
Numerous prior studies have suggested a significant association between ELS and 
white matter abnormalities in adults with and without psychopathology (e.g., depression, 
PTSD; Benedetti et al., 2014; Choi et al., 2009; Frodl et al., 2012; Huang, Gundapuneedi, 
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& Rao 2012; Lu et al., 2013; Paul et al., 2008; Seckfort et al., 2008). Importantly, there is 
significant overlap between the white matter neuroimaging signatures of HIV and ELS. 
For example, reduced white matter integrity in the corpus callosum is frequently 
observed in individuals with ELS (Benedetti et al., 2014; Huang et al., 2012; Lu et al., 
2013; Paul et al., 2008; Seckfort et al., 2008). Research has also demonstrated significant 
relationships between ELS and white matter abnormalities in tracts traversing the frontal 
lobe such as the cingulum bundle, uncinate fasciculus, inferior longitudinal fasciculus, 
inferior fronto-occipital fasciculus, and superior longitudinal fasciculus (Choi et al., 2009, 
2012; Benedetti et al., 2014; Frodl et al., 2012; Huang et al., 2012). Collectively, these 
studies provide support that ELS may be associated with white matter integrity in 
adulthood.  
 The relationship between ELS and cognitive function is unclear. While one pilot 
study in healthy adults revealed that ELS may be associated with poorer memory 
performance (Majer, Nater, Lin, Capuron, & Reeves, 2010), most studies have focused 
on cognition and ELS in the context of overt pychopathology, including those with PTSD 
(Bremner, Vermetten, Afzal, & Vythilingam, 2004; Navalta, Polcari, Webster, 
Boghossian, & Teicher, 2006), schizophrenia (Aas et al., 2012; Lysaker, Myer, Evans, & 
Marks, 2001; Shannon et al., 2009), and major depressive disorder (MDD; Gould et al., 
2012). However, it is important to note these relationships are not consistently observed 
in individuals with psychopathology (Stein, Koverola, Hanna, C, Torchia, & McClarty, 
1997; Stein, Hanna, Vaerum, & Koverola, 1999) or in larger samples of otherwise 
healthy adults (Seckfort et al., 2008). Results from animal studies are more consistent. 
For example, rodents and non-human primates exhibit reduced learning and memory 
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following exposure to ELS (Aisa, Tordera, Lasheras, Del Río, & Ramírez, 2007; Avital, 
Ram, Maayan, Weizman, & Richter-Levin, 2006; Brunson et al., 2005; Meaney et al., 
1991; Naninck et al., 2015; Sánchez, Hearn, Do, Rilling, & Herndon, 1998). These 
studies suggest that ELS may have direct links to cognitive ability, but research focused 
on ELS and cognition in humans has provided mixed support for this relationship. As 
such, the potential association between ELS and cognitive performance is unclear.  
Summary 
Two studies suggest a significant association between ELS and poorer cognitive 
outcomes in HIV+ individuals (Clark et al., 2012; Spies et al., 2016), however the 
relationship between co-morbid HIV and ELS on brain volumes remains unclear. 
Additionally, no study to date examined the relationship between HIV and ELS with 
white matter integrity. The present study addressed this important area by examining gray 
and white matter integrity, as well as cognition in 130 HIV+ and 76 HIV– individuals 
with high and low ELS exposure (assessed by the ELSQ). Participants underwent 
structural MRI, DTI, and neuropsychological assessment. All HIV+ participants were on 
HAART and all participants were free of major psychiatric illness and neurological 
confounds. It was hypothesized that HIV+ individuals with high ELS would exhibit 
abnormal DTI indices in the cingulum bundle, uncinate fasciculus, and corpus callosum 
and lower brain volumes in the anterior cingulate cortex, caudate, putamen, amygdala, 
hippocampus, and corpus callosum compared to HIV+ individuals with low ELS and 
HIV– controls. It was also predicted that reduced neuropsychological performance in the 
domains of executive function, psychomotor/processing speed, and learning would be 
observed in HIV+ individuals with high ELS compared to the two HIV– control groups. 
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The objective of this study was to develop a more comprehensive understanding of the 
relationship between high ELS with neuroimaging outcomes and cognitive function in 
HIV+ individuals.  
Study Overview 
The study was funded by the National Institutes of Health (F31-MH105308; PI: 
Ms. Laurie Baker; Mentors: Drs. Robert Paul, Beau Ances, and Michael Griffin). The 
data were extracted from three larger studies focused on brain integrity in adults with 
HIV (R01-NR012657; R01-NR012907; R01-NR014449; PI: Dr. Beau Ances). The 
parent grants did not focus on ELS, and therefore the current study reflected a unique 
element of research that leveraged the strengths of existing studies.  
Research Design Considerations 
A number of important methodological design issues were considered to ensure 
high scientific rigor. The initial design consideration was whether the retrospective, self-
report measure of ELS (ELSQ) was an adequate assessment of ELS. Retrospective 
reports of ELS are often subject to recall bias (Hardt & Rutter 2004), therefore 
prospective studies of ELS on the brain are preferable. However, this approach was not 
feasible in this particular cohort given that individuals were evaluated in adulthood. 
Fortunately, numerous studies reveal that the ELSQ is sensitive to alterations in brain 
integrity related to ELS (Baker et al., 2013; Cohen et al., 2006a; Gatt et al., 2009; Paul et 
al., 2008; Seckfort et al., 2008) and co-morbid HIV and ELS (Clark et al., 2012; Clark et 
al., 2016). Furthermore, this measure has strong internal consistency ( = 0.90) and test-
retest reliability (r = 0.89; p < 0.001).  
The second consideration was the method to classify ELS groups. Numerous 
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previous studies utilized a cut point of ≥ 2 (Cohen et al., 2006a; Hoth et al., 2006) or ≥ 3 
ELS events (Clark et al., 2012, 2016; Korgaonkar et al., 2013; McFarlane et al., 2005; 
Paul et al., 2008; Seckfort et al., 2008) on the ELSQ to define high ELS. In the present 
study, ≥ 3 ELS events was chosen as the threshold for high ELS to allow for direct 
comparison with the most relevant extant literature in co-morbid HIV and ELS (Clark et 
al., 2012). Additionally, previous studies using the ELSQ defined low or no ELS by < 3 
(Clark et al., 2012; Korgaonkar et al., 2013; Seckfort et al., 2008) or 0 ELS events 
(Cohen et al., 2006a; McFarlane et al., 2005; Paul et al., 2008). A cut-point of < 3 allows 
for maximum data inclusion in the present study and is consistent with recent literature in 
co-morbid HIV and ELS (Clark et al., 2012; Clark et al., 2016). As such, the final 
classification rules for primary analyses were: 1) high ELS defined by ≥ 3 ELS events, 2) 
low ELS defined by < 3 ELS events.  
One limitation of the selected method is that a cut-point of < 3 to define low ELS 
does not provide a large distinction between high and low ELS groups. Therefore, 
exploratory analyses were used to determine whether differences in brain integrity were 
present between individuals with high ELS defined by ≥ 3 ELS events and low ELS 
defined by < 2 ELS events. While 0 ELS events would allow for maximum distinction 
between groups, only 11% of HIV+ participants reported no ELS, consistent with rates 
observed in prior HIV studies (Clark et al., 2012, 2016; Mugavero et al., 2006), while 
24% reported < 2 ELS events. Additionally, studies have demonstrated a dose-response 
curve between ELS events and brain abnormalities (Cohen et al., 2006a; Paul et al., 
2008), therefore the number of ELS events was examined as a continuous variable in 
exploratory analyses. Lastly, childhood abuse and neglect are frequently associated with 
Baker, Laurie, 2017, UMSL, p. 13 
 
neuroimaging abnormalities (Anderson et al., 2008; Chaney et al., 2014; Stein et al., 
1997), therefore exploratory analyses examined whether individuals that experienced 
abuse and/or neglect exhibited worse brain outcomes than those that experienced other 
forms of ELS.  
 The third consideration was the selection of white matter tracts. The corpus 
callosum is a dense white matter tract containing interhemispheric cortical connections 
and abnormalities in this region are frequently associated with cognitive dysfunction 
(Hoare et al., 2012a&b; Sullivan, Adalsteinsson, & Pfefferbaum, 2006; Wu et al., 2006). 
Studies have reported white matter abnormalities in the corpus callosum in HIV+ 
individuals (Filippi et al., 2001; Heaps-Woodruff et al., 2016; Tate et al., 2010; Wright, 
Heaps, Shimony, Thomas, & Ances, 2012; Wu et al., 2006) and in adults with ELS 
(Benedetti et al., 2014; Frodl et al., 2012; Huang et al., 2012; Lu et al., 2013; Paul et al., 
2008; Poletti et al., 2015; Seckfort et al., 2008). As such, the corpus callosum is an ideal 
target to investigate co-morbid HIV and ELS on white matter integrity. The uncinate 
fasciculus and cingulum bundle connect prefrontal, medial temporal, and the cingulate 
cortices and are associated with aspects of executive functioning, 
psychomotor/processing speed, and learning, as well as emotional processing (Etkin, 
Egner, & Kalisch, 2011; Schulte, Müller-Oehring, Sullivan, & Pfefferbaum, 2012; Davis 
et al., 2009; Diao et al., 2015; Johnson et al., 2011; Sasson, Doniger, Pasternak, Tarrasch, 
& Assaf, 2013). Further, these tracts are independently associated with HIV (Fillippi et 
al., 2001; Heaps-Woodruff et al., 2016, Wright et al., 2012; Paul et al., 2016; Wu et al., 
2006) and ELS (Choi et al., 2009; Huang et al., 2012; Lu et al., 2013; Paul et al., 2008; 
Poletti et al., 2015; Seckfort et al., 2008). Therefore, the present study focused on the 
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corpus callosum, uncinate fasciculus, and cingulum bundle as primary white matter tracts 
of interest. Several studies have also demonstrated widespread white matter injury in 
HIV+ individuals (Baker et al., 2017; Chen et al., 2009; Nir et al., 2014; Ragin, Storey, 
Cohen, Edelman, & Epstein, 2004; Ragin, Storey, Cohen, Epstein, & Edelman, 2004; 
Stubbe-Dräger et al., 2012; Su et al., 2016; Underwood et al., 2017). As such, whole-
brain white matter integrity at the voxel level was examined as an exploratory aim. 
Method 
Participants 
 Data from 130 HIV+ individuals with an average age of 51.0 years (SD = 13.2) 
and 13.0 years of education (SD = 2.7), and 76 HIV– individuals with an average age of 
35.6 years (SD = 16.0) and 13.8 years of education (SD = 2.0) were extracted from 
archival databases. Participants were recruited from the Washington University School of 
Medicine (WUSM) Infectious Disease Clinic in Saint Louis, the WUSM AIDS Clinical 
Trial Group (ACTG) community medical providers, and local organizations. A similar 
recruitment strategy was employed for all participants in attempt to match the HIV+ and 
HIV– groups on demographic and historical factors that could negatively impact brain 
integrity. Participation was voluntary and individuals were informed they could withdraw 
from the study at any time. Written informed consent was obtained following a thorough 
explanation of the study procedures. Cognitive data, ELS quantification, participant 
demographics and relevant health histories were obtained at WUSM. Neuroimaging 
procedures were completed in all individuals at WUSM within one week of the 
neuropsychological visit. The Institutional Review Board of the University of Missouri- 
St. Louis and WUSM approved the study protocol as part of the parent grants and the 
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NIH F31 award. All participants received financial compensation for their involvement in 
the study. 
Inclusion/Exclusion Criteria 
 
Individuals were included in the study if they met the following criteria: 1) at least 
18 years of age; 2) at least 8 years of formal education; and 3) initiation of HAART at 
least three months prior to enrollment for HIV+ individuals. HIV− controls were 
administered a rapid oral HIV buccal test to confirm a negative result at the time of 
enrollment. Participants were excluded if they met any of the following criteria: 1) unable 
to provide written consent determined by the failure to answer questions outlined in the 
informed consent about study procedures, risks, and, benefits of study; 2) any 
neurological disorders associated with neurocognitive impairment other than HIV (e.g., 
multiple sclerosis); 3) active opportunistic infection (e.g., cytomegalovirus encephalitis, 
cryptococcal meningitis, toxoplasma encephalitis); 4) HCV co-infection; 5) lifetime 
history of head injury with a loss of consciousness > 30 minutes; 6) major psychiatric 
illness (e.g., schizophrenia, bipolar disorder), PTSD, or current severe depression 
(determined by a score ≥ 29 on the Beck Depression Inventory-II; BDI-II; Beck, Steer, & 
Brown, 1996); 7) pregnancy determined by a urine pregnancy test prior to testing; and 8) 
contraindications for MRI (e.g., claustrophobia, metal exposure).  
Disease Characteristics 
HIV serostatus was determined using an HIV antibody test and confirmed by 
Western blot. A blood sample was obtained from all HIV+ participants to measure CD4 
T-cell counts and plasma HIV viral load within 30 days prior to neuropsychological 
assessment and neuroimaging acquisition. Nadir CD4 T-cell count, duration of infection, 
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duration of HAART, estimated gap between HIV diagnosis and initiation of HAART, 
and type of HAART regimen were obtained from self-report or medical records, when 
available. 
Early Life Stress Questionnaire (ELSQ) 
The ELSQ is based on the Child Abuse and Trauma Scale (Sanders & Becker-
Lausen, 1995). The ELSQ consists of 19 items that ask whether or not the individual 
experienced ELS events such as physical abuse, emotional abuse, sexual abuse, bullying, 
neglect, poverty, parental divorce, and domestic violence. The participants were asked to 
respond “yes” or “no” to each event and identify the age of onset (0–17 years of age). 
The high ELS group was defined by the endorsement of ≥ 3 ELS events. The low ELS 
group was defined by the endorsement of < 3 ELS events. Individuals were divided into 
four groups for primary analyses (HIV+/high ELS n = 91; HIV+/low ELS n = 39; HIV–
/high ELS n = 45; HIV–/low ELS n = 31). For exploratory analyses, the high ELS group 
was defined by the endorsement of ≥ 3 ELS events and the low ELS group was defined 
by the endorsement of < 2 ELS events (HIV+/high ELS n = 91; HIV+/low ELS n = 23; 
HIV–/high ELS n = 45; HIV–/low ELS n = 27). For additional exploratory analyses, 
HIV+ individuals were separated into two groups based on whether or not they 
experienced abuse and/or neglect by the endorsement of one or more of the following 
questions on the ELSQ: 1) Were you physically abused? 2) Were you sexually abused? 3) 
Were you emotionally abused? 4) Did you experience extreme poverty or neglect?  
Beck Depression Inventory II (BDI-II) 
The BDI-II (Beck et al., 1996) is a 21-item self-report instrument intended to 
assess the existence and severity depression symptoms as listed in the Diagnostic and 
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Statistical Manual of Mental Disorders Fourth Edition (DSM-IV; American Psychiatric 
Association, 1994). A total score of 0–13 is considered minimal depression, 14–19 is 
mild, 20–28 is moderate, and 29–63 is severe. Participants with a BDI-II total score ≥ 29 
were excluded.  
Neuroimaging 
Neuroimaging Acquisition 
All neuroimaging was obtained at WUSM on a 3T Siemens Tim Trio whole body 
MR scanner at (Siemens AG, Erlangen Germany) using a 12-channel transmit/receive 
head coil. A T1-weighted three-dimensional magnetization-prepared rapid acquisition 
gradient echo (MPRAGE) sequence (time of repetition/inversion time/echo time = 
2400/1000/3.16 ms, flip angle=8°, and voxel size=1 x 1 x 1 mm3) was obtained. Two 
acquisitions of diffusion-weighted images were collected and subsequently averaged for 
the assessment of white matter microstructural integrity (2 x 2 x 2 mm3 voxels, TR= 9900 
ms, TE = 102 ms, flip angle =90°, 23 directions with multiple b values ranging between 0 
and 1400 s/mm2).  
Diffusion Tensor Imaging Processing 
DTI preprocessing included correction for eddy current distortions followed by 
skull stripping (Smith, 2002) using FSL 5.0.9 (www.fmrib.ox.ac.uk/fsl/). Scans 
confounded by head movement > 3 mm were discarded (Strain et al., 2017). Tensor 
calculation for FA, MD, AD, and RD were derived using the Functional Magnetic 
Resonance Imaging of the Brain (FMRIB) software library (FSL) for preparation of tract 
based spatial statistics (TBSS; Smith et al., 2006).  
A voxel-wise analysis was performed using the TBSS package, part of FSL 
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(Smith et al., 2006). FA maps were aligned to the FA standard image using the FMRIB 
nonlinear image registration tool (Jenkinson & Smith, 2001; Jenkinson, Bannister, Brady, 
& Smith, 2002). A group specific mean FA map was created and thinned to produce a 
mean skeleton. A threshold of FA = 0.25 was used as it provides confidence that the 
voxels selected are primarily white matter voxels rather than voxels consisting of partial 
gray/partial white matter. Contrast analyses of the entire white matter skeleton for each 
diffusion metric were performed using the “Randomise” tool in FSL (Winkler, Ridgway, 
Webster, Smith, & Nichols, 2014). A Monte Carlo permutation based approach was used 
to correct for multiple comparisons (Smith & Nichols, 2009). 
In addition to the voxel-wise analysis of the skeletonized data, tract-wise analyses 
were conducted by isolating the portions of the TBSS-derived skeleton that fell within the 
boundaries of a priori white matter tract regions. The cingulum bundle (cingulate gyrus 
segment of cingulum and hippocampal segment of cingulum) and uncinate fasciculus 
were modeled separately by hemisphere and streamlines were selected for inclusion using 
the JHU atlas (Mori, Wakana, Nagae-Poetscher, & Van Zijl, 2005). Additionally, a mask 
of the whole corpus callosum was manually traced on the midsagittal slice of the T2-
weighted image. The adjacent slices were checked to ensure that the midsagittal slice 
contained the full corpus callosum. 
Volumetric Analysis 
Quantification of regional volumes was obtained using the FreeSurfer software 
suite (v5.1) (Martinos Center, Harvard University, Boston, MA; 
http://surfer.nmr.mgh.harvard.edu). This automated software program transforms the 
MPRAGE scan of an individual into a template space with the skull stripped and the 
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brain segmented into white matter, gray matter, and ventricles. Brain regions were 
parcellated into subcortical and cortical regions of interest (ROI) using a surface 
deformation program (Dale, Fischl, & Sereno, 1999; Fischl et al., 1999; Desikan et al., 
2006). Images from all subjects were aligned onto a common atlas (MNI305) (Fischl et 
al. 2004). For this analysis, strategic ROIs included: anterior cingulate cortex, caudate, 
putamen, amygdala, hippocampus, and corpus callosum. All volumetric analyses 
included total intracranial volume (ICV) as a covariate to control for individual 
differences in head size. 
Neuropsychological Assessment  
 All participants completed a comprehensive neuropsychological evaluation at 
WUSM. The neuropsychological tests were chosen based on established sensitivity to 
HIV–associated cognitive dysfunction (Baker et al., 2014, 2015; Grant, 2008; Robertson 
et al., 2007). Raw scores from each cognitive test were included in analyses. For 
descriptive purposes, raw scores were converted to standardized z-scores using published 
normative standards with adjustments for demographics where applicable (Supplemental 
Table 2; Benedict, Schretlen, Groninger, & Brandt, 1998, Delis, Kaplan, & Kramer, 
2001; Friedman, Schinka, Mortimer, & Graves, 2002; Heaton, Miller, Taylor, & Grant, 
2004.; Lucas et al., 2005; Norman et al., 2011; Piatt, Fields, Paolo,& Tröster, 2004; 
Wechsler, 1997; Woods et al., 2005b). Individual test z-scores were averaged by domain 
to create domain-specific z scores (psychomotor/processing speed, executive function, 
learning). Participants were classified as cognitively impaired if they had a z score of < –
1.0 in two or more cognitive domains or a z score of < –2.0 in at least one cognitive 
domain. Classified in this manner, 33% of HIV+ individuals demonstrated cognitive 
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impairment, generally consistent with numerous studies in the HAART-era (Heaton et al., 
2010; McCutchan et al., 2007; Sacktor et al., 2016; Robertson et al., 2007), compared 
with 24% in the HIV– group. Rates of cognitive impairment in each group (HIV+/high 
ELS; HIV+/low ELS; HIV–/high ELS; HIV–/low ELS) are reported in Table 1.  
Psychomotor/Processing Speed 
The following tests measured psychomotor/processing speed: 1) Trails A from the 
Trail Making Test (Reitan & Davison, 1974), 2) Grooved Pegboard-dominant and non-
dominant hand (Kløve, 1963), and 3) Digit Symbol from the Wechsler Adult Intelligence 
Scale-III (WAIS-III; Wechsler, 1997). Trails A requires participants to connect a series of 
numbers in numerical order such that a line is drawn from 1 to 2 to 3, etc. Time to 
completion in seconds was the primary outcome measure. During the Grooved Pegboard 
test, participants are asked to insert grooved metal pegs into holes aligned in different 
rotations. The pegs must be rotated to match the hole before they can be inserted. 
Participants start with their dominant hand and place the pegs into the holes as fast as 
they can without skipping any, then must complete the same task with their non-dominant 
hand. Time to completion was the primary outcome measure for both dominant and non-
dominant hands. The Digit Symbol task requires participants to match symbols to their 
corresponding digit. The primary outcome measure was total correct in 120 seconds.  
Executive Function 
 The following tests were used to measure executive function: 1) Trails B from the 
Trail Making Test (Reitan & Davison, 1974), 2) Verb Fluency (Piatt, Fields, Paolo, & 
Tröster, 1999), 3) Letter Number Sequencing (LNS) from the WAIS-III (Wechsler, 
1997), and 4) Trial 3 of the Color Word Interference Task (CWIT; Delis, Kaplan, & 
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Kramer, 2001). Trails B requires participants to connect numbers in ascending order and 
letters in alphabetical order in an alternating sequence. Numbers and letters are connected 
by drawing a line from 1 to A, A to 2, 2 to B, etc. Time to completion was the primary 
outcome measure. Verb fluency requires participants to recite as many verbs as they can 
in 60 seconds. The number of correctly stated verbs on the entire test was the primary 
outcome measure. LNS requires participants to arrange a series of numbers and letters 
within a string by placing numbers in order first, followed by letters in alphabetical order. 
Each letter-number string has a distinct amount of characters (begins with 2 and ends at 
9) and there are three strings within a block. The task is concluded once a participant fails 
to complete all three strings within a block. The number of successfully completed strings 
was the primary outcome measure. During Trial 3 of the CWIT, participants are 
presented with four rows of color-words (e.g. the word red) that are printed in a 
contrasting color-word combination (e.g. the word red printed in blue ink). Participants 
are required to identify the ink color of each color-word. Time to completion was the 
primary outcome measure.  
Learning 
The Hopkins Verbal Learning Test-Revised (HVLT-R; Brandt & Benedict, 2001) 
was administered to measure learning. The HVLT-R consists of a 12-item word list, 
composed of four words from three semantic categories (e.g. precious stones, human 
shelter, animals). Participants are asked to recall the words, in any order, after the list had 
been read to them. The primary outcome measure was the total number of recalled words 
over three trials. Immediate recall is most commonly impacted by HIV, therefore the 
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retention and recognition subtests of the HVLT-R were not included in analyses (Cohen, 
Seider, & Navia, 2015; Grant, 2008; Woods, Moore, Weber, & Grant,  2009).  
Statistical Analyses 
Data Cleaning:  
Data was screened for outliers (z ≥ ±3 standard deviations from the group mean) 
and missing values. The number of missing cases represented less than 10% in each 
group, therefore mean imputation was employed to address missing data (Peng, Harwell, 
Liou, & Ehman, 2006 Pineau, Marchand, & Guay, 2014; Tabachnick & Fidell, 2007). 
Data were screened for normality using Q-Q plots. Results of these analyses concluded 
that DTI, brain volume, and neuropsychological data did not violate assumptions of 
normality.  
Factorial univariate analyses of variance/univariate analyses of covariance 
(ANOVA/ANCOVA) or multivariate analyses of variance/multivariate analyses of 
covariance (MANOVA/MANCOVA) models were used for all primary analyses. Each 
dependent variable was checked for normality, linearity, multivariate outliers, 
homogenous covariance matrices, and multicollinearity to ensure all variables met 
necessary assumptions for using these statistical tests. Variables that were non-normally 
distributed were log transformed and re-examined for normality. Pillai’s Trace was used 
to report results for MANOVAs that violated statistical assumptions of homogeneity of 
variance (Box’s M < 0.001, Bartlett’s test > 0.001, Levene’s test < 0.05; Meyers, Gamst, 
& Guarino, 2006). Assumptions were met unless otherwise noted in the results. Statistical 
significance was determined using an alpha level of 0.05. False discovery rate (FDR; 
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Benjamini & Hochberg, 1995) corrections were implemented for all family-wise analyses 
to control Type 1 error rate.  
Examination of demographic, disease, and psychiatric variables: 
Preliminary analyses examined demographic, disease, and psychiatric variables 
between the four groups for primary analyses (HIV+/high ELS, HIV+/low ELS, HIV–
/high ELS, HIV–/low ELS). Separate ANOVAs were used to determine if the groups 
differed in age, years of education, and/or BDI-II across the four groups. Chi-square 
analyses determined potential differences in sex, race, and self-reported drug and alcohol 
use (≥ 1 instance of self- reported use in last 6 months) between the four groups. Separate 
independent samples t-tests were conducted to detect potential differences in current CD4 
T-cell count, nadir CD4 T-cell count, current viral load (log10 transformed), duration of 
infection, duration of HAART, and estimated gap between HIV diagnosis and initiation 
of HAART between the HIV+/high ELS group and HIV+/low ELS group. Potential 
differences in the number of detectable (> 20 RNA copies/ml) versus undetectable viral 
load (≤ 20 RNA copies/ml) and types of HAART regimens were examined using chi-
squared analyses. Demographic, disease, and psychiatric variables that differed 
significantly (p < 0.05) between groups and were at least moderately correlated (r ≥ 0.30 
with one or more of the dependent variables) were included as covariates in the main 
analyses to control for intervening effects on the outcome measures (Tavakoli, 2012).  
Differences in demographic, disease, and psychiatric variables were also 
examined between groups. For Exploratory Aim 3, independent samples t-tests for 
continuous variables (e.g., age, education) and chi-square analyses for categorical 
variables (e.g., sex, race) were used to determine differences between HIV+ individuals 
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that experienced abuse and/or neglect and those that did not. For Exploratory Aim 4, the 
same variables were analyzed between the four groups with high ELS defined by ≥ 3 
ELS events and low ELS defined by < 2 ELS events (HIV+/high ELS n = 92; HIV+/low 
ELS n = 23; HIV–/high ELS n = 45; HIV–/low ELS n = 27) using separate ANOVAs for 
continuous variables and chi-square analyses for categorical variables. Demographic, 
disease, and psychiatric variables that differed significantly (p < 0.05) between groups 
and were at least moderately correlated (r ≥ 0.30 with one or more of the dependent 
variables) were included as covariates in the respective exploratory analyses. 
Data Reduction: 
Correlation analyses between DTI metrics revealed strong associations (r’s > 
0.70) between MD and RD for nearly all tracts. Therefore, MD was eliminated from 
analyses to reduce redundancy. Correlations between FA, RD, and AD were < 0.70 
across each of the tracts, therefore all three metrics were used in analyses. Bivariate 
correlations revealed moderate to large correlations between all imaging indices obtained 
in the left and right hemispheres (r’s = 0.50-0.80). As such, the tracts were aggregated 
into single bilateral tracts, consistent with prior work (e.g., Filippi et al., 2001; Pomara et 
al., 2001; Thurnher et al., 2005; Wu et al., 2006).  
Primary Aims 
Analytic Plan for Aim 1: Determine the association between ELS and white 
matter integrity in HIV+ and HIV– individuals. H1: HIV+ individuals with high 
ELS will exhibit significantly lower FA and higher AD and RD in the corpus 
callosum, uncinate fasciculus, and cingulum bundle compared to HIV+ individuals 
with low ELS and HIV– individuals with high and low ELS. Three separate 2x2 
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factorial MANCOVAs with factors of HIV status (HIV+, HIV–) and ELS status (low 
ELS, high ELS) were used to compare FA, AD, and RD values between the four groups 
and to examine the interaction between HIV and ELS status. Age and sex were controlled 
in each MANCOVA (Table 1). HIV and ELS status served as the independent variables 
in each analysis and FA, AD, and RD values served as the dependent variables. If a 
significant HIV x ELS interaction was observed, follow-up analyses of the simple main 
effects (mean differences between the HIV+/high ELS, HIV+/low ELS, HIV–/high ELS, 
and HIV–/low ELS groups) were conducted. If the interaction analysis did not 
demonstrate statistical significance, the main effects (HIV status and ELS status) were 
then examined for significance. In the presence of significant main effects for HIV and/or 
ELS, univariate analyses were used to determine which white matter tract diffusion 
values differed significantly between groups. Group means were examined to determine 
the direction of any significant main effects.  
Analytic Plan for Aim 2: Determine the association between ELS and gray 
matter volumes in HIV+ and HIV– individuals. H2: HIV+ individuals with high ELS 
will exhibit smaller volumes in the anterior cingulate cortex, hippocampus, 
putamen, amygdala, corpus callosum and caudate compared to HIV+ individuals 
with low ELS and HIV– individuals with and high and low ELS. A 2x2 factorial 
MANCOVA with factors of HIV status (HIV+, HIV–) and ELS status (low ELS, high 
ELS) was used to compare brain volumes between the four groups and to examine the 
interaction between HIV and ELS status. Age, sex, and ICV were controlled in the 
MANCOVA (Table 1). HIV and ELS status served as the independent variables in each 
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analysis and brain volumes served as the dependent variables. Follow-up analyses were 
conducted, if necessary, as described in Primary Aim 1.  
Analytic Plan for Aim 3:  Determine the association between ELS and 
neuropsychological performance in HIV+ and HIV– individuals. H3: HIV+ 
individuals with high ELS will perform more poorly on tests of 
psychomotor/processing speed, executive function, and learning compared to HIV– 
individuals with high and low ELS. Raw scores on psychomotor/processing speed, 
executive function, and learning tests were analyzed in three separate 2x2 factorial 
MANCOVAs (or ANCOVA, when appropriate) (one for each domain). Factors of HIV 
status (HIV+, HIV–) and ELS status (low ELS, high ELS) were used to compare 
performance between the four groups and to examine the interaction between HIV and 
ELS status. HIV and ELS status served as the independent variables in each analysis and 
raw scores on each cognitive test served as the dependent variables. Each analysis 
controlled for age and sex (Table 1). Follow-up analyses were conducted, if necessary, as 
described in Primary Aim 1. H4: Alterations in white matter tract integrity and brain 
volumes will predict cognitive performance in HIV+ individuals with high ELS. 
Bivariate correlations were utilized to determine whether the cognitive tests that 
significantly differed between groups in Primary Aim 3 were associated with white 
matter tracts and brain volumes that significantly differed between groups in Primary 
Aims 1 and 2. 
Exploratory Aims  
Exploratory Aim 1: Examine the relationship between ELS and whole-brain 
white matter integrity using voxel-wise analyses in HIV+ and HIV– individuals. 
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Analyses of the entire white matter skeleton for each diffusion metric were performed 
using the “Randomise” tool in FSL. F-tests with factors of HIV status (HIV+, HIV–) and 
ELS status (low ELS, high ELS) were used to examine the interaction between HIV 
status and ELS status on whole-brain FA, AD, and RD. HIV and ELS status served as the 
independent variables in each analysis and whole-brain FA, AD, and RD values served as 
the dependent variables Follow-up analyses were conducted, if necessary, as described in 
Primary Aim 1. Each analysis controlled for age and sex at the voxel level and correction 
for multiple comparisons was conducted using a Monte Carlo 5000 permutation based 
approach (Smith & Nichols, 2009).  
Exploratory Aim 2: Investigate the cumulative effect of ELS on white matter 
integrity, brain volumes, and cognitive performance in HIV+ individuals. Linear 
regression analyses were utilized to examine the relationship between the total number of 
ELS events and DTI metrics, brain volumes, and neuropsychological performance. The 
first component was addressed through regression models including the number of ELS 
events as the independent variable and FA, AD, and RD values of the white matter tracts 
of interest as the dependent variables (one linear regression for each DTI metric). The 
second component was addressed through regression models including the number of 
ELS events as the independent variable and brain volumes as the dependent variables, 
controlling for ICV. The third component was addressed through regression models 
including the number of ELS events as the independent variable and raw scores within 
each neuropsychological domain (one linear regression for each domain for 
psychomotor/processing speed and executive function) as the dependent variables. A 
bivariate correlation was used to examine the relationship between number of ELS events 
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and learning. 
Exploratory Aim 3: Determine differences in neuroimaging outcomes and 
neuropsychological performance in HIV+ individuals who experienced abuse and/or 
neglect and those that did not. The HIV+ group was separated into two groups based on 
whether or not they endorsed one or more abuse and/or neglect items on the ELSQ, 
regardless of high or low ELS grouping in the primary analyses. Separate ANOVAS or 
MANOVAS (ANCOVAs or MANCOVAs, where appropriate) were used to examine 
differences in DTI metrics, volumes, and cognition between groups with history of 
abuse/neglect and those without. The abuse/neglect groups described above served as the 
independent variable and diffusion metrics (one model for each diffusion metric), brain 
volumes, and cognitive test performance (one model for each domain) served as the 
dependent variables. The analysis examining differences in brain volumes controlled for 
ICV.  
Exploratory Aim 4:  Determine the association between ELS and white matter 
integrity, brain volumes, and neuropsychological performance in HIV+ and HIV– 
individuals with high ELS defined by ≥ 3 ELS events and low ELS defined by < 2 
ELS events. Separate 2x2 factorial MANCOVAs (or ANCOVAs, when appropriate) 
with factors of HIV status (HIV+, HIV–) and ELS status (low ELS; < 2 ELS events, high 
ELS; ≥ 3 ELS events) were used to compare diffusion metrics, brain volumes, and 
cognitive test performance between the four groups and to examine the interaction 
between HIV and ELS status. The same statistical procedures as described in Primary 
Aims 1-3 were implemented for each MANCOVA (or ANCOVA). Age and sex were 
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controlled in each MANCOVA (or ANCOVA, when appropriate). ICV was also included 
as a covariate in the analysis examining brain volumes.  
Results 
Data Screening and Preliminary Analyses 
The final sample was comprised of 206 participants. Overall, the entire sample 
included 140 males (68%) and 66 females (32%). The majority of participants were 
African American (57%), followed by Caucasian (40%), multi-racial (2%), and Asian 
(1%). The average age collapsed across groups was 45.5 years (SD = 16.01; range = 18-
80) and the average education level was 13.6 years (SD = 2.5; range = 8-20).  
Comparisons by HIV/ELS groups indicated that the groups significantly differed 
in age (F(3, 202) = 20.31, p = 0.02, ƞp² = 0.23), sex (χ²(3, n = 206) = 23.67, p < 0.01, 
Cramer’s V = 0.33) and BDI-II score (F(3, 201) = 3.48, p < 0.01, ƞp² = 0.05). Age was 
significantly related to a majority of the dependent variables in each primary analysis (r’s 
> 0.30, p’s < 0.05). Additionally, independent samples t-tests revealed significant 
differences between males and females in numerous dependent variables for each 
primary aim (p’s < 0.05). As such, both variables were included as covariates in the 
primary analyses. BDI-II scores were significantly different between HIV/ELS groups, 
however scores were not moderately correlated with any DTI metrics, brain volumes, or 
individual neuropsychological test scores (r < 0.30). Therefore, BDI-II score was not 
included as a covariate in primary analyses. No group differences were observed for 
years of education (F(3, 202) = 1.14, p = 0.33, ƞp² = 0.02) or race (χ²(12, n = 206) = 
15.47, p = 0.22, V = 0.16). Further, no significant differences were present between the 
four groups self-reported use in the last 6 months of opioids (χ²(3, n = 185) = 2.43, p = 
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0.49, V = 0.12), amphetamines (χ²(3, n = 184) = 4.62, p = 0.20, V = 0.20), crack/cocaine 
(χ²(3, n = 187) = 3.12, p = 0.37, V = 0.37), marijuana (χ²(3, n = 198) = 1.28, p = 0.73, V 
= 0.08), or alcohol (χ²(3, n = 196) = 1.04, p = 0.79, V = 0.07).  
There were no significant differences in disease factors including duration of 
infection (t(128) = 1.29, p = 0.20, d = 0.25), current viral load (t(121) = –0.11, p = 0.28, d 
= 0.01), number of individuals with detectable versus undetectable viral load χ²(1, n = 
123) = 0.21, p = 0.64, V = 0.04), current CD4 T-cell count (t(120) = 0.78, p = 0.39, d = 
0.15), nadir CD4- T- cell count (t(109) = –0.13 , p = 0.87, d = 0.02), duration of HAART 
(t(127) = 0.93, p = 0.35, d = 0.21), estimated gap between HIV diagnosis and initiation of 
HAART (t(122) = 1.16, p = 0.25, d = 0.18), and type of HAART regimen (χ²(3, n = 129) 
= 2.95, p = 0.40, V = 0.15). All HIV+ participants were on HAART. Sample 
characteristics are listed in Table 1. 
 No significant differences between demographic, disease, and psychiatric 
variables were observed between HIV+ individuals that experienced abuse and/or neglect 
and those experienced other types of ELS (p’s > 0.05), therefore no covariates were used 
in Exploratory Aim 3. However, comparisons by HIV/ELS groups (high ELS defined by 
≥ 3 ELS events and low ELS defined by < 2 ELS events) indicated that the groups 
significantly differed in age (F(3, 182) = 18.09, p < 0.01, ƞp² = 0.23), sex (χ²(3, n = 186) 
= 25.27, p < 0.01, V = 0.34), and BDI-II score (F(3, 186) = 3.78, p = 0.01, ƞp² = 0.06). 
Age was significantly related to a majority of the dependent variables in each primary 
analysis (r’s > 0.30, p’s < 0.05). Additionally, independent samples t-tests revealed 
significant differences between males and females in numerous dependent variables for 
each primary aim (p’s < 0.05). As such, both variables were included as covariates in the 
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primary analyses. BDI-II scores were significantly different between HIV/ELS groups, 
however scores were not moderately correlated with any DTI metrics, brain volumes, or 
individual neuropsychological test scores (r < 0.30). Therefore, BDI-II score was not 
included as a covariate in Exploratory Aim 4. No other significant differences in 
demographic, psychiatric, or disease characteristics were observed between the four 
groups (p’s > 0.05). 
Primary Aims  
No HIV x ELS interaction was observed for FA (Wilks’ Λ = 0.99, F(4, 195) = 
0.12, p = 0.98, ƞp² < 0.01), AD (Wilks’ Λ = 0.99, F(4, 192) = 0.50, p = 0.74, ƞp² = 0.01), 
or RD (Pillai’s Trace = 0.01, F(4, 193) = 0.24, p = 0.91, ƞp² < 0.01). Additionally, no 
main effects of HIV were observed on FA (Wilks’ Λ = 0.98, F(12, 195) = 0.57, p = 0.97, 
ƞp² < 0.01), AD (Wilks’ Λ = 0.97, F(4, 192) = 1.66, p = 0.16, ƞp² = 0.03), or RD (Pillai’s 
Trace = 0.01, F(4, 193) = 0.37, p = 0.83, ƞp² < 0.01). There were also no main effects of 
ELS on FA (Wilks’ Λ = 0.99, F(4, 195) = 0.39, p = 0.69, ƞp² = 0.01), AD (Wilks’ Λ = 
0.97, F(4, 192) = 1.66, p = 0.66, ƞp² = 0.01), or RD (Pillai’s Trace = 0.01, F(4, 193) = 
0.29, p = 0.88, ƞp² < 0.01; Table 2). 
Similarly, no HIV x ELS interaction was observed on brain volumes (Wilks’ Λ = 
0.98, F(6, 187) = 0.70, p = 0.65, ƞp² = 0.02). However, there was a significant main effect 
of HIV on brain volumes (Wilks’ Λ = 0.91=9, F(6, 187) = 3.51, p < 0.01, ƞp² = 0.10). 
Univariate analyses revealed that HIV+ individuals exhibited smaller brain volumes in 
the amygdala F(1, 192) = 11.28, p < 0.01, ƞp² = 0.06), putamen F(1, 192) = 11.69, p < 
0.01, ƞp² = 0.06), corpus callosum F(1, 192) = 4.60, p = 0.03, ƞp² = 0.02), and 
hippocampus (F(1, 192) = 16.44, p < 0.01, ƞp² = 0.08) when compared to HIV– controls. 
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All significant differences among individual brain regions survived FDR correction for 
multiple comparisons. There was no significant main effect of ELS on brain volumes 
(Wilks’ Λ = 0.98, F(6, 187) = 0.62, p = 0.72, ƞp² = 0.02; Table 3).  
No significant HIV x ELS interaction was observed on executive function (Wilks’ 
Λ = 0.98, F(4, 191) = 0.79, p = 0.53, ƞp² = 0.02). However, results revealed a significant 
main effect for HIV on executive function (Wilks’ Λ = 0.93, F(4, 191) = 3.63, p < 0.01, 
ƞp² = 0.07). Univariate results revealed that HIV+ individuals performed worse on Trial 3 
of the CWIT (F(1, 191) = 12.36, p < 0.01, ƞp² = 0.06), LNS (F(1, 191) = 4.66, p = 0.03, 
ƞp² = 0.02), and verb fluency (F(1, 191) = 5.87, p = 0.02, ƞp² = 0.03) when compared to 
HIV– individuals. All significant differences among individual tests survived FDR 
correction for multiple comparisons. There was no significant main effect for ELS on 
executive function (Wilks’ Λ = 0.96, F(4, 191) = 1.90, p = 0.11, ƞp² = 0.04). Additionally, 
there was no significant HIV x ELS interaction for psychomotor/processing speed 
(Wilks’ Λ = 0.96, F(4, 187) = 1.99, p = 0.10, ƞp² = 0.04). There were also no significant 
main effects of HIV (Wilks’ Λ = 0.98, F(4, 187) = 1.11, p = 0.35, ƞp² = 0.02) or ELS 
(Wilks’ Λ = 0.98, F(4, 187) = 0.89, p = 0.47, ƞp² = 0.02) on psychomotor/processing 
speed. Furthermore, no significant HIV x ELS interaction was observed on learning (F(1, 
199) = 0.07, p = 0.80, ƞp² < 0.01). Additionally, there was no significant main effect of 
HIV (F(1, 199) = 2.43, p = 0.12, ƞp² = 0.01) or ELS (F(1, 199) = 0.03, p = 0.87, ƞp² < 
0.01; Table 4) on learning. Overall, no significant HIV x ELS interactions were observed 
on DTI metrics, brain volumes, or neuropsychological performance. Therefore, 
regressions examining the relationship between white matter integrity in specific tracts of 
interest and brain volumes with cognition were not examined. 
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Exploratory Aims 
Exploratory Aim 1: No significant HIV x ELS interaction was observed on 
whole-brain FA. However, results revealed significant main effects for HIV on FA (p < 
0.05; Figure 1), with lower FA in HIV+ individuals. Additionally, there was a significant 
main effect for ELS on FA (p < 0.05; Figure 2), with individuals in the high ELS 
exhibiting lower FA than individuals with low ELS. There was no significant HIV x ELS 
interaction for whole-brain RD. However, a trend level main effect for HIV on RD was 
observed (p = 0.08), with higher RD in HIV+ individuals, particularly in areas of the 
temporal lobe and external capsule (Figure 3). Additionally, a main effect for ELS on RD 
was observed at a trend level (p = 0.09), with individuals with high ELS exhibiting higher 
RD than individuals with low ELS, particularly in areas of the frontal lobes (Figure 4). 
There was no significant HIV x ELS interaction on whole-brain AD. Furthermore, no 
significant main effects for HIV or ELS were observed on AD. Mean skeletal values for 
DTI metrics are included in Supplemental Table 3.  
Exploratory Aim 2: The average number of ELS events in the HIV+ group was 
4.14 (SD = 2.91; Range 0-14). Linear regressions examining the relationship between 
DTI metrics and number of ELS events identified no significant relationships with FA 
values (F(4, 123) = 0.90, p = 0.46, f 2 = 0.03), AD values (F(4, 120) = 1.73, p = 0.15, f 2 = 
0.06), or RD values (F(4, 121) = 0.84, p = 0.50, f 2 = 0.03). Additionally, there were no 
significant relationships observed between the number of ELS events and brain volumes 
(F(7, 126) = 0.77, p = 0.61, f 2 = 0.04). Lastly, no significant relationships were evident 
between the number of ELS events and tests of executive function (F(4, 115) = 0.76, p = 
0.55, f 2 = 0.03), psychomotor/processing speed (F(4, 117) = 1.15, p = 0.34, f 2 = 0.04), or 
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learning (r = 0.09, p = 0.31). 
Exploratory Aim 3: There were no significant differences between HIV+ 
individuals that reported abuse and/or neglect (n = 64) and those that did not report abuse 
and/or neglect (n = 67) on FA values (Wilks’ Λ = 0.99, F(1, 126) = 0.38, p = 0.82, ƞp² = 
0.01), AD values (Wilks’ Λ = 0.73, F(4, 123) = 0.73, p = 0.57, ƞp² = 0.02), or RD values 
(Pillai’s Trace = 0.01, F(4, 121) = 0.44, p = 0.78, ƞp² = 0.01). No significant differences 
between groups were observed for brain volumes (Wilks’ Λ = 0.99, F(6, 119) = 0.14, p = 
0.99, ƞp² = 0.01). Lastly, executive function (Wilks’ Λ = 0.99, F(4, 123) = 0.38, p = 0.82, 
ƞp² = 0.01), psychomotor/processing speed (Wilks’ Λ = 0.98, F(4, 117) = 0.73, p = 0.57, 
ƞp² = 0.02), and learning (F(1, 129) = 1.48, p = 0.23, ƞp² = 0.01) performance did not 
differ between the two groups. 
Exploratory Aim 4: No significant HIV x ELS interaction was observed for FA 
(Wilks’ Λ = 0.99, F(4, 174) = 0.09, p = 0.99, ƞp² < 0.01), AD (Wilks’ Λ = 0.99, F(4, 171) 
= 0.48, p = 0.75, ƞp² = 0.01), or RD (Pillai’s Trace = 0.01, F(4, 172) = 0.43, p = 0.78, ƞp² 
= 0.01) with high ELS defined by ≥ 3 ELS events and low ELS defined by < 2 ELS 
events. Additionally, no main effects of HIV were observed on FA (Wilks’ Λ = 0.99, 
F(4, 174) = 0.57, p = 0.68, ƞp² = 0.01), AD (Wilks’ Λ = 0.96, F(4, 171) = 1.87, p = 0.12, 
ƞp² = 0.04), or RD (Pillai’s Trace = 0.01, F(4, 172) = 0.38, p = 0.82, ƞp² < 0.01). There 
were also no main effects of ELS on FA (Wilks’ Λ = 0.99, F(4, 174) = 0.15, p = 0.96 ƞp² 
< 0.01), AD (Wilks’ Λ = 0.97, F(4, 171) = 1.21, p = 0.31, ƞp² = 0.03), or RD (Pillai’s 
Trace = 0.02, F(4, 172) = 0.67, p = 0.60, ƞp² = 0.02).  
Similarly, no HIV x ELS interaction was observed on brain volumes (Wilks’ Λ = 
0.99, F(6, 169) = 0.21, p = 0.97, ƞp² < 0.01). However, there was a significant main effect 
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of HIV on brain volumes (Wilks’ Λ = 0.92, F(6, 169) = 2.62, p = 0.20, ƞp² = 0.09). 
Univariate analyses revealed that HIV+ individuals exhibited smaller brain volumes in 
the amygdala F(1, 174) = 8.67, p < 0.01, ƞp² = 0.05), putamen F(1, 174) = 9.39, p < 0.01, 
ƞp² = 0.05), and hippocampus (F(1, 174) = 10.98, p < 0.01, ƞp² = 0.06) when compared to 
HIV– controls. All significant differences among individual brain regions survived FDR 
correction for multiple comparisons. There was no significant main effect of ELS on 
brain volumes (Wilks’ Λ = 0.98, F(6, 167) = 0.65, p = 0.69, ƞp² = 0.02).  
Lastly, no significant HIV x ELS interaction was observed on executive function 
(Wilks’ Λ = 0.97, F(4, 168) = 1.15, p = 0.33; ƞp² = 0.03). However, results revealed a 
significant main effect for HIV on executive function (Wilks’ Λ = 0.92, F(4, 168) = 2.49, 
p < 0.01, ƞp² = 0.08). Univariate results revealed that HIV+ individuals performed worse 
on Trial 3 of the CWIT (F(1, 171) = 9.48, p < 0.01, ƞp² = 0.05), LNS (F(1, 171) = 4.69, p 
= 0.03, ƞp² = 0.03), and verb fluency (F(1, 171) = 6.68, p = 0.03, ƞp² = 0.04) when 
compared to HIV– individuals. All significant differences among individual tests 
survived FDR correction for multiple comparisons. There was no significant main effect 
for ELS on executive function (Wilks’ Λ = 0.97, F(4, 168) = 1.30, p = 0.26, ƞp² = 0.03). 
Additionally, there was no significant HIV x ELS interaction for psychomotor/processing 
speed (Wilks’ Λ = 0.97, F(4, 166) = 1.49, p = 0.21, ƞp² = 0.04). There were also no 
significant main effects of HIV (Wilks’ Λ = 0.98, F(4, 166) = 0.99, p = 0.41, ƞp² = 0.02) 
or ELS (Wilks’ Λ = 0.98, F(4, 166) = 0.78, p = 0.54, ƞp² = 0.02) on 
psychomotor/processing speed. Furthermore, no significant HIV x ELS interaction was 
observed on learning (F(1,184) = 0.005, p = 0.95, ƞp² < 0.01). Additionally, there was no 
significant main effect of HIV on learning (F(1, 184) = 1.14, p = 0.29, ƞp² < 0.01) or ELS 
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(F(1, 184) = 0.09, p = 0.77, ƞp² < 0.01). 
Discussion 
The primary goal of this research was to determine if high ELS contributes to 
brain structural and cognitive abnormalities in HIV+ individuals. There were no 
significant interactions between HIV and ELS on neuroimaging outcomes or 
neuropsychological performance. However, results revealed significantly greater whole-
brain white matter microstructural abnormalities, smaller brain volumes, and lower 
cognition in HIV+ individuals when compared to HIV– controls. Individuals with high 
ELS also demonstrated greater whole-brain white matter microstructural abnormalities 
compared to individuals with low ELS, independent of HIV serostatus. Neither HIV nor 
high ELS was associated with white matter tract abnormalities in the uncinate fasciculus, 
cingulum bundle, or corpus callosum. Collectively, findings from the present study do 
not suggest that high ELS is a major contributor to brain dysfunction in HIV+ individuals 
on HAART. 
 Co-morbid HIV and ELS and Neuroimaging and Cognitive Outcomes 
 Studies have revealed that ELS may contribute to HIV-related gray matter 
abnormalities (Spies et al., 2016) and reduced neuropsychological performance (Clark et 
al., 2012; Spies et al., 2016). Furthermore, white matter abnormalities have been 
observed in individuals with HIV (e.g., Fillippi et al., 2001; Heaps-Woodruff et al., 2016, 
Paul et al., 2016; Wu et al., 2006) and ELS (e.g., Choi et al., 2009; Huang et al., 2012; Lu 
et al., 2013; Paul et al., 2008; Seckfort et al., 2008), independently. Therefore, it was 
predicted that ELS would contribute to HIV-related abnormalities in gray matter 
volumes, white matter microstructural integrity, and neuropsychological performance. In 
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contrast to the proposed hypotheses, results did not reveal a significant interaction 
between HIV and ELS on brain integrity. Exploratory findings also did not suggest that 
co-morbid HIV and high ELS was associated with HIV-related brain dysfunction using 
multiple methods to quantify ELS events (i.e., total number of ELS events experienced, 
prior abuse and/or neglect, or low ELS defined by < 2 ELS events on ELSQ).  
 These findings differ from data presented in previous studies of co-morbid HIV 
and ELS on brain integrity (Clark et al., 2012, Spies et al., 2016). Importantly, the most 
robust negative effects of HIV and ELS were observed in a cohort of HIV+ individuals 
with limited HAART use (< 50%; Spies et al., 2016), whereas all individuals in the 
present study were on HAART. The HIV+ group in Spies et al. (2016) exhibited a 
notably higher viral load (M = 116,172 copies/ml, range = < 20-3,200,000 copies/ml, % 
undetectable viral load not reported) and a lower CD4 T-cell count (M = 431 cells/μl, 
range = 25-1,529 cells/μl), on average, compared to individuals in the present study (viral 
load M = 2,069 copies/ml, range = < 20-2,069 copies/ml, 81% undetectable viral load; 
CD4 T-cell count M = 601 cells/μl, range = 56-1,462 cells/μl). Therefore, it is possible 
that the negative effect of ELS in HIV+ individuals may emerge in the context of greater 
immunosuppression and is not present in individuals with largely suppressed viremia. 
Future longitudinal studies examining co-morbid HIV and ELS on brain integrity pre- 
and post-HAART use may help to elucidate this possibility. 
HIV on Neuroimaging and Cognitive Outcomes 
 
 The HIV+ group exhibited significantly greater global white matter abnormalities 
compared with HIV– controls in the absence of pronounced differences in the localized 
tracts examined (i.e., uncinate fasciculus, cingulum bundle, corpus callosum), suggesting 
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subtle white matter injury widely distributed throughout the brain. A similar widespread 
pattern of white matter abnormalities has been observed in individuals on antiretroviral 
therapy and with suppressed viremia (Nir et al., 2014; Su et al., 2016; Underwood et al., 
2017). Specifically, HIV+ individuals in the present study exhibited significantly lower 
global FA and higher global RD, at a trend level, compared to HIV– individuals, with the 
most robust differences in RD evident in the temporal lobes and external capsule. This 
pattern of altered DTI metrics (low FA, high RD) has previously been observed in HIV+ 
individuals (Leite et al., 2013; Li et al., 2015; Underwood et al., 2017) and possibly 
reflects pronounced demyelination (Song et al., 2002). However, more recent research 
indicates a complex interpretation in which RD may be considered a marker of both axon 
and myelin integrity (Madden et al., 2012). Overall, these results extend findings of prior 
studies demonstrating whole-brain white matter injury in HAART-treated HIV+ 
individuals.  
 Results revealed evidence of residual gray matter and cognitive abnormalities in 
HIV+ individuals on HAART. Consistent with prior research, (Ances et al., 2006, 2012; 
Behrman-Lay et al., 2016; Baker et al., 2015; Becker et al., 2012; Paul et al., 2016; 
Sanford et al., 2017), HIV+ individuals demonstrated significantly lower volumes of the 
putamen, amygdala, corpus callosum, and hippocampus compared with HIV– controls. In 
terms of cognition, the HIV+ group exhibited a greater rate of cognitive impairment 
(33%) compared with the HIV– group (24%), an observation driven by lower executive 
performance in HIV+ individuals. Specifically, a significant main effect of HIV 
serostatus on executive function was observed, with HIV+ individuals performing 
significantly worse on Trial 3 of the CWIT, LNS, and Verb Fluency compared with HIV– 
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controls. These findings are similar to previous research demonstrating executive 
dysfunction in HIV+ individuals despite successful viral suppression (Antinori et al., 
2007; Baker et al., 2015; Heaton et al., 2010; Woods et al., 2009). Collectively, these 
outcomes underscore the chronic nature of brain and cognitive dysfunction associated 
with HIV and suggest the need for interventions, such as cognitive rehabilitation (Becker 
et al., 2012), among HIV+ individuals on HAART to improve executive function.  
ELS, Neuroimaging, and Cognitive Outcomes 
In contrast to some previous studies (Choi et al., 2009; Lu et al., 2013; Poletti et 
al., 2015; Paul et al., 2008; Seckfort et al., 2008; Wu et al., 2006), results did not reveal 
localized disruption to the uncinate fasciculus, cingulum bundle, or corpus callosum in 
individuals with high ELS. However, the high ELS group exhibited significantly lower 
whole-brain FA and higher whole-brain RD, at a trend level, compared with the low ELS 
group, likely indicating diffuse disruption to axonal and myelin integrity (Madden et al., 
2012). Results revealed the most prominent abnormalities in individuals with high ELS 
were localized to the frontal lobe (Figures 2 and 4). Inflammation may be one of many 
important drivers of these abnormalities in individuals with ELS (Fagundes & Way 2014; 
Kiecolt-Glaser et al., 2011; Raposa, Bower, Hammen, Najman, & Brennan, 2014). 
Chronic inflammation is common in individuals with ELS and may be due to increased 
cortisol production in response to stressors (van der Vegt, van der Ende, Kirschbaum, 
Verhulst, & Tiemeier, 2009). The persistence of high cortisol levels can lead to the 
production of proinflammatory cytokines, which affect synaptic production, axonal 
pruning, and myelination (reviewed in Glaser, 2000; Gunnar and Ouevedo, 2008). It has 
been suggested that the frontal lobe is particularly vulnerable to the effects of 
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inflammation due to protracted postnatal development, a high density of glucocorticoid 
receptors, and postnatal neurogenesis (Gogtay et al., 2004; Teicher et al., 2003).  
 There were no significant differences in brain volumes between individuals with 
high and low ELS, suggesting that the impact of high ELS may not be severe enough to 
induce gross morphological changes in this cohort. These data are consistent with prior 
work in co-morbid HIV and ELS (Clark et al., 2012), yet are inconsistent with the many 
studies demonstrating volumetric atrophy in the context of ELS, even in the absence of 
psychopathology in adulthood (Andersen et al., 2008; Baker et al., 2013; Cohen et al., 
2006a; Korgaonkar et al., 2013; Saleh, Potter, McQuoid, & Boyd, 2016). It is possible 
that the method used to define low ELS (< 3 on the ELSQ in primary analyses and < 2 
ELS events on the ELSQ in secondary analyses) may have contributed to the lack of 
significant differences observed between high and low ELS groups. Importantly, the most 
robust brain volume differences in adults without psychopathology were observed 
between individuals with no ELS (0 ELS events on the ELSQ) compared to individuals 
with high ELS (≥ 3 ELS events on the ELSQ; Cohen et al., 2006a). However, this method 
was not feasible in the present study, given insufficient power resulting from a low rate of 
individuals that reported no ELS exposure (11% in HIV+ group, 7% in HIV– group).  
 It is also possible that genetic variants of particular genes may contribute to the 
vulnerability or resilience of brain integrity in the context of early life stressors. Previous 
research has suggested that the influence of ELS on brain volumes in adulthood is 
partially moderated by risk alleles of the serotonin transporter (5-HTTLPR; Frodl et al., 
2010a), the glutamate transporter polymorphism SLC1A2-181A>C (Poletti et al., 2014), 
and the brain-derived neurotrophic factor Val66Met (Carballedo et al., 2013; Gatt et al., 
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2009) genetic polymorphisms in adults with and without psychopathology. Therefore, 
differences in genetics may have contributed the findings in the present study, however 
these relationships could not be assessed, as genotyping was not conducted. Nevertheless, 
future studies should continue to elucidate genetic and environment modifiers of ELS on 
brain integrity. 
Individuals with high ELS did not exhibit lower neuropsychological performance 
when compared to individuals with low ELS, regardless of HIV serostatus. These results 
are consistent with some prior work in adults without psychopathology (Seckfort et al., 
2008). Importantly, a majority of the studies demonstrating a significant relationship 
between ELS and cognition have consisted of participants with PTSD, MDD, and 
schizophrenia (Bremner et al., 2004; Gould et al., 2012; Lysaker et al., 2001; Navalta et 
al., 2006; Saleh et al., 2017; Shannon et al., 2009). The present findings, in conjunction 
with some previous research, suggest that cognitive dysfunction associated with ELS may 
not be evident on formal neuropsychological measures in the absence of 
psychopathology. However, it is also possible that the specific neuropsychological tests 
used in the present study contributed to the lack of significant differences. While the 
neuropsychological tests administered were sensitive to effects of HIV (Carey et al., 
2004; Woods et al., 2005a), the battery was not designed to measure cognitive outcomes 
of co-morbid HIV and ELS. Prior studies in ELS have demonstrated that more complex 
measures, such as the California Verbal Learning Test-II (Delis, Kramer, Kaplan, & 
Ober, 2000) and the Wisconsin Card Sorting Test (Heaton, Chelune, Talley, Kay, & 
Curtis, 1992) are sensitive to the effects of ELS (Aas et al., 2011, Lyasker et al., 2001; 
Spies et al., 2017). As such, it remains unknown whether the behavioral phenotype 
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related to ELS would have been captured utilizing a larger and more comprehensive 
neuropsychological battery.  
Conclusions should be tempered by several limitations. Retrospective self-reports 
of ELS are subject to recall bias (Hardt & Rutter, 2004). While significant effects of high 
ELS were identified in brain white matter, it remains unknown whether that the absence 
of an HIV and ELS interaction was influenced by the use of a retrospective ELS 
assessment. Therefore, prospective studies of the effects of ELS on brain integrity may be 
preferable in future studies. It is also possible that the salience and intensity of early 
adverse events influenced outcomes in the present study (Cohen et al., 2006b), however 
these elements are not included in the ELSQ. Accordingly, an assessment of ELS 
capturing these specific details is warranted. Furthermore, the HIV+ groups differed with 
respect to age and sex, such that the HIV+ group, on average, was significantly older than 
the HIV– group and consisted of more male participants. Although age and sex were 
controlled in analyses, it remains possible that these demographic differences may have 
had an indirect influence on the findings. Lastly, the current study utilized a cross-
sectional study design and future longitudinal studies would allow for a more direct 
observation of the effects of HIV and ELS on brain integrity. 
Conclusion 
There is high rate of variability in HIV-related brain dysfunction. Although prior 
research has demonstrated that ELS may contribute to this variability, there were no 
significant HIV and ELS interactions on white matter microstructural integrity, brain 
volumes, or cognition in the present study. Overall, these data indicate that ELS does not 
represent a primary driver of the neuropathogenic model of HIV in the HAART era. 
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Nevertheless, persistent negative effects of HIV and high ELS on brain integrity were 
observed, which is consistent with prior research. Future studies are needed to confirm 
the interaction of HIV and ELS along the HIV disease continuum and to further elucidate 
the individual impact of HIV and ELS on health and wellness. 
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Table 1  
Demographic Characteristics for Primary Aims 
 
 
HIV+/high ELS  HIV+/low ELS HIV–/high ELS HIV–/low ELS 
Variable n = 91 n = 39 n = 45 n = 31 
Mean age (years) (SD)* 50.71 (13.26) 52.46 (12.52) 33.73 (16.01) 38.16 (15.90) 
Mean education (years) (SD) 13.30 (2.77) 14.00 (2.92) 13.98 (2.06) 13.42 (1.82) 
Ethnic composition 
      % Caucasian 38% 33% 47% 42% 
  % African American 59% 64% 51% 52% 
  % American Indian 1% 0% 0% 0% 
  % Asian 0% 0% 0% 6% 
  % Multiracial 2% 3% 2% 0% 
% Male* 79% 82% 49% 45% 
Mean BDI-II score (SD)* 9.15 (7.34) 8.18 (7.37) 6.60 (5.63) 4.90 (6.59) 
Mean number of ELS events 
(SD)* 5.47 (2.41) 1.03 (0.90) 5.29 (2.14) 0.90 (0.60) 
Mean duration of infection 
(years) (SD)  16.05 (9.16) 13.69 (7.86) - - 
% on HAART 100% 100% - - 
Duration of HAART (years) 
(SD)  12.80 (7.69) 11.41 (7.44)   
Years between diagnosis and 
HAART (SD)  2.12 (2.41) 1.44 (2.71)   
Mean nadir CD4 (cells/μl) (SD)  179.22 (175.31) 183.15 (166.86) - - 
Mean current CD4 (cells/μl) 
(SD)  620.20 (311.05) 570.00 (262.20) - - 
Mean viral load (SD) 1.55 (0.70) 1.56 (0.87) - - 
% undetectable viral load (< 20 
copies/ml)  81% 82% - - 
% HAART treatment regimen      
  NRTI + NNRTI 34% 33%   
  NRTI + PI 12% 23%   
  NRTI + INSTI 27% 26%   
  Other HAART 27% 18%   
% Substance Use (last 6 months)     
  Alcohol  68% 68% 75% 64% 
  Opiates  2% 0% 0% 0% 
  Crack/Cocaine  10% 7% 3% 4% 
  Marijuana  33% 38% 32% 25% 
  Amphetamines  1% 1% 0% 0% 
% Cognitive Impairment 31% 40% 29% 16% 
Note. a Viral load log10 transformed; *Significant difference between groups p < 0.05; 
BDI-II = Beck Depression Inventory-II; NRTI = nucleotide reverse transcriptase 
inhibitor; NNRTI = nonnucleoside reverse transcriptase inhibitor; PI = protease inhibitor; 
INSTI = integrase strand transfer inhibitors; HAART = highly active antiretroviral 
therapy 
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Table 2  
 
DTI Metrics in HIV/ELS Groups 
 
HIV+/high ELS HIV+/low ELS HIV–/high ELS HIV–/low ELS 
DTI Metric M (SD) M (SD) M (SD) M (SD) 
Fractional Anisotropy 
    
Uncinate Fasciculus 0.54 (0.04) 0.55 (0.03) 0.55 (0.03) 0.55 (0.04) 
Cingulate gyrus segment of 
cingulum 
0.60 (0.03) 0.60 (0.03) 0.60 (0.03) 0.61 (0.03) 
Hippocampal segment of 
cingulum 
0.51 (0.06) 0.52 (0.05) 0.50 (0.06) 0.50 (0.06) 
Corpus Callosum 0.77 (0.04) 0.77 (0.03) 0.79 (0.04) 0.78 (0.02) 
Axial Diffusivity (10-2) 
    
Uncinate Fasciculus 0.12 (0.00) 0.12 (0.00) 0.12 (0.00) 0.12 (0.00) 
Cingulate gyrus segment of 
cingulum 
0.11 (0.00) 0.12 (0.00) 0.12 (0.00) 0.12 (0.00) 
Hippocampal segment of 
cingulum 
0.09 (0.00) 0.09 (0.00) 0.09 (0.00) 0.10 (0.00) 
Corpus Callosum 0.14 (0.00) 0.14 (0.00) 0.14) (0.00) 0.14 (0.00) 
Radial Diffusivity (10-3) 
    
Uncinate Fasciculus 0.46 (0.00) 0.46 (0.00) 0.45 (0.00) 0.45 (0.00) 
Cingulate gyrus segment of 
cingulum 
0.34 (0.00) 0.34 (0.00) 0.34 (0.00) 0.33 (0.00) 
Hippocampal segment of 
cingulum 
0.42 (0.00) 0.41 (0.00) 0.43 (0.00) 0.43 (0.00) 
Corpus Callosum 0.28 (00.00) 0.28 (0.00) 0.26 (0.00) 0.26 (0.00) 
Note. *Significant difference between groups p < 0.05 following FDR correction; DTI = 
diffusion tensor imaging 
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Table 3 
Brain Volumes in HIV/ELS Groups 
  HIV+/high ELS HIV+/low ELS HIV–/high ELS HIV–/low ELS 
Brain Region of 
Interest cm3 M (SD) M (SD) M (SD) M (SD) 
Anterior cingulate 
cortex 8.40 (1.38) 8.11 (1.27) 8.81 (1.65) 8.43 (1.26) 
Hippocampus* 7.84 (1.06) 7.59 (0.85) 8.23 (0.86) 8.35 (0.73) 
Amygdala* 3.27 (0.49) 3.21 (0.38) 3.50 (0.46) 3.51 (0.31) 
Caudate 7.01 (0.97) 6.87 (0.93) 7.34 (1.04) 7.27 (1.22) 
Putamen* 10.51 (1.35) 10.26 (1.07) 11.73 (1.44) 11.48 (1.33) 
Corpus callosum* 3.02 (0.53) 2.87 (0.46) 3.17 (0.44) 3.21 (0.50) 
Note. *Significant difference between groups p < 0.05 following FDR correction  
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Table 4  
Cognitive Test Scores in HIV/ELS Groups  
  HIV+/high ELS HIV+/low ELS HIV–/high ELS HIV–/low ELS 
Cognitive Test M (SD) M (SD) M (SD) M (SD) 
Psychomotor/Processing 
Speed     
Trails A^ 31.64 (10.38) 33.86 (11.82) 29.66 (9.97) 26.09 (9.03) 
Grooved Pegboard- dominant 
hand^ 
76.88 (16.59) 77.20 (9.15) 67.74 (12.53) 67.05 (11.18) 
Grooved Pegboard- 
nondominant hand^ 
84.91 (17.79) 90.69 (13.31) 80.55 (15.86) 77.76 (12.96) 
Digit Symbol Substitution 
Test  
64.99 (15.66) 65.23 (18.30) 76.12 (14.97) 77.65 (17.46) 
Executive Function* 
    
Trails B^ 82.32 (32.02) 85.04 (33.23) 72.42 (30.88) 61.51 (16.44) 
Verb Fluency* 12.96 (5.77) 12.57 (6.32) 17.51 (7.67) 15.71 6.69) 
LNS* 8.53 (3.00) 9.30 (2.81) 10.39 (2.55) 11.04 (2.47) 
Trial 3 of the CWIT*^ 67.67 (17.21) 65.29 (17.86) 52.09 (14.06) 49.94 (12.71) 
Learning 
    
HVLT-R Learning 21.91 (5.60) 21.74 (6.13) 24.09 (4.57) 24.00 (4.85) 
Note. *Significant difference between groups p < 0.05 following FDR correction; ^ 
indicates lower score equals better performance; LNS = letter number sequencing; 
HVLT-R = Hopkins Verbal Learning Test-Revised  
Baker, Laurie, 2017, UMSL, p. 76 
  
 
 
 
Figure 1. TBSS voxel-wise comparison of fractional anisotropy (FA) differences 
between HIV+ individuals and HIV– individuals on diffusion tensor imaging. Orange 
indicates voxels in which FA is lower in HIV+ individuals than HIV– individuals (p < 
0.02, corrected). Red indicates voxels in which FA is lower in HIV+ individuals than 
HIV– individuals (p < 0.03, corrected). Blue indicates voxels in which FA is lower in 
HIV+ individuals than HIV– individuals (p < 0.04, corrected). Green indicates voxels in 
which FA is lower in HIV+ individuals than HIV– individuals (p < 0.05, corrected). 
Axial images are in radiologic orientation with the results thickened for better visibility 
using the tract-based spatial statistics “fill” script.
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Figure 2. TBSS voxel-wise comparison of fractional anisotropy (FA) differences 
between individuals with high ELS and individuals with low ELS on diffusion tensor 
imaging. Orange indicates voxels in which FA is lower in high ELS than low ELS (p 
< 0.02, corrected). Red indicates voxels in which FA is lower in high ELS than low 
ELS (p < 0.03, corrected). Blue indicates voxels in which FA is lower in high ELS 
than low ELS (p < 0.04, corrected). Green indicates voxels in which FA is lower in 
high ELS than low ELS (p < 0.05, corrected). Axial images are in radiologic 
orientation with the results thickened for better visibility using the tract-based spatial 
statistics “fill” script.
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Figure 3. TBSS voxel-wise comparison of radial diffusivity (RD) differences 
between HIV+ individuals and HIV– individuals on diffusion tensor imaging. Orange 
indicates voxels in which RD is higher in HIV+ individuals than HIV– individuals (p 
< 0.05, corrected). 
 
 
 
Figure 4. TBSS voxel-wise comparison of radial diffusivity (RD) differences 
between individuals with high ELS and low ELS on diffusion tensor imaging. Orange 
indicates voxels in which RD is higher in individuals with high ELS than individuals 
with low ELS (p < 0.05, corrected).  
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Supplement 
Supplemental Table 1 
Correlations Between Brain volumes and Cognition (Spies et al., 2016) 
Cognitive Domain Brain Volume 
  
Motor Skills Anterior Cingulate Cortex 
  
Processing Speed Anterior Cingulate Cortex 
 Corpus Callosum 
 Amygdala 
 Caudate 
  
Learning Hippocampus 
  
Verbal Fluency Hippocampus 
 Corpus Callosum 
  
Attention/Working Memory Corpus Callosum 
  
Abstraction/Executive Function Amygdala 
 Caudate 
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Supplemental Table 2 
 
Neuropsychological Test Battery and Normative Data   
 
Neuropsychological domain and tests Normative data sources 
Learning   
Hopkins Verbal Learning Test- Revised (Total Immediate 
Recall) 
Benedict, Schretlen, Groninger & Brandt 
(1998)1; Friedman et al., 20021,2,3; Norman et 
al., 20112,3 
Psychomotor/Processing Speed  
WAIS-III Digit Symbol Weschler (1997)1 
Trail Making Test (Part A) 
Heaton, Miller, Taylor & Grant (2004)1,2,3,4; 
Lucas et al., 20051,2,4 
Grooved Pegboard (dominant hand) Heaton, Miller, Taylor & Grant (2004)1,2,3,4 
Grooved Pegboard (non-dominant hand) Heaton, Miller, Taylor & Grant (2004)1,2,3,4 
Executive Function  
WAIS-III Letter Number Sequencing Weschler (1997)1 
Trial 3 of the Color Word Interference Task Delis, Kaplan, & Kramer (2001)1 
Trail Making Test (Part B) 
Heaton, Miller, Taylor & Grant (2004)1,2,3,4; 
Lucas et al., 20051,2,4 
Verb Fluency Piatt et al., 20041,2; Woods et al., 2005b2 
 Note. WAIS-III = Wechsler Adult Intelligence Scale-III; Normative data indicated by 
superscript number- 1 = age, 2 =education, 3= gender, 4= ethnicity 
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Supplemental Table 3  
Whole-Brain DTI Skeletal Values in HIV/ELS Groups 
 
HIV+/high ELS HIV+/low ELS HIV–/high ELS HIV–/low ELS 
DTI Metric M (SD) M (SD) M (SD) M (SD) 
Fractional Anisotropy 0.49 (0.02) 0.50 (0.03) 0.50 (0.22) 0.51 (.02) 
Axial Diffusivity (10-2) 0.11 (0.00) 0.11 (0.00) 0.11 (0.00) 0.11 (0.00) 
Radial Diffusivity (10-3) 0.49 (0.00) 0.48 (0.00) 0.47 (0.00) 0.48 (0.00) 
 
